Skip to main content
. Author manuscript; available in PMC: 2020 Mar 1.
Published in final edited form as: AIDS Behav. 2019 Mar;23(3):580–591. doi: 10.1007/s10461-018-2269-0

Table I:

Characteristics of Study Population Based on Encounters from Feb 17, 2005 to July 31, 2016 in which a PHQ-9 was Completed*

Initial Visit All Visits
Moderate-Severe
Symptoms of
Depression
(PHQ-9 ≥10) 		No-Mild
Symptoms of
Depression
(PHQ-9 <10) 		Moderate-Severe
Symptoms of
Depression
(PHQ-9 ≥ 10) 		No-Mild
Symptoms of
Depression
(PHQ-9 < 10)
All, % (n) 25.5% (3,522) 74.5% (10,265) 22% (11,420) 78% (40,418)
Age, mean [IQR] 43.0 [35.6–50.2] 44.7 [36.4–52.4] 45.6 [39–52.3] 46.6 [38.9–54.1]
Female 18.2% (641) 16.6% (1,700) 18.7% (2,139) 16.8% (6,802)
Race, %(n)
 White 51.1% (1,801) 46.2% (4,746) 51.2% (5,843) 46.5% (18,810)
 Black 28.5% (1,004) 36.1% (3,710) 29.4% (3,353) 36.8% (14,888)
 Hispanic 15.2% (537) 13% (1,331) 15.4% (1,753) 12.8% (5,193)
 Other 5.1% (180) 4.7% (478) 4.1% (471) 3.8% (1,527)
MSM, % (n) 68.5% (2414) 65.8% (6,756) 67.8% (7,740) 67% (27,078)
Years since enrollment in cohort, mean [IQR] 3.5 [0.3–6] 4.4 [0.5–7.6] 5.5 [1.5–8.6] 6.4 [2–10.1]
On antidepressant therapy, %(n) 32.3% (1,139) 17.4% (1,783) 40.8% (4,664) 22% (8,898)
Alcohol Use, %(n†)
 None 33.2% (1,110) 35.4% (3,504) 37.3% (4,045) 36.5% (14,240)
 Moderate 29.7% (993) 32.7% (3,240) 30.5% (3,305) 34.9% (13,585)
 Heavy 37.1% (1,240) 31.9% (3,165) 32.2% (3,487) 28.6% (11,136)
Recent Cocaine Use, % (n†) 12.6% (425) 6.6% (659) 9.8% (1,078) 5.2% (2,036)
Recent Opioid Use, % (n†) 5.0% (164) 1.9% (178) 4.3% (462) 1.4% (546)
Recent Methamphetamine Use, % (n†) 18.5% (620) 8.0% (796) 13.9% (1,518) 6.3% (2,462)
†

Not all subjects completed the PRO questions for alcohol, cocaine, opioid, and methamphetamine use, so the denominators are less than the total numbers of subjects. IQR = Interquartile range